OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic fatty liver disease: Evolving paradigms
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 36, pp. 6571-6592
Open Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
Kiarash Riazi, Hassan Azhari, Jacob H Charette, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 9, pp. 851-861
Closed Access | Times Cited: 1270

Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
Zobair M. Younossi, Maria Stepanova, Janus P. Ong, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 3, pp. 580-589.e5
Open Access | Times Cited: 415

Beneficial Effects of Betaine: A Comprehensive Review
Madan Kumar Arumugam, Matthew C. Paal, Terrence M. Donohue, et al.
Biology (2021) Vol. 10, Iss. 6, pp. 456-456
Open Access | Times Cited: 177

Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello, Antonino Di Pino, Roberto Scicali, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1948-1948
Open Access | Times Cited: 169

Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 270-270
Open Access | Times Cited: 135

Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
Eda Kaya, Yusuf Yılmaz
Journal of Clinical and Translational Hepatology (2021) Vol. 10, Iss. 2, pp. 329-338
Open Access | Times Cited: 118

Risk assessment with gut microbiome and metabolite markers in NAFLD development
Howell Leung, Xiaoxue Long, Yueqiong Ni, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 648
Open Access | Times Cited: 78

Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 328-348
Open Access | Times Cited: 130

Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, et al.
Annals of Hepatology (2020) Vol. 19, Iss. 4, pp. 359-366
Open Access | Times Cited: 122

Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
Xuefeng Ma, Shousheng Liu, Jie Zhang, et al.
BMC Gastroenterology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 119

Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
Amedeo Lonardo, Ayako Suzuki
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1278-1278
Open Access | Times Cited: 109

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
Pegah Golabi, James M. Paik, Rashmi Reddy, et al.
BMC Gastroenterology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 97

Ghrelin reduces TNF-α-induced human hepatocyte apoptosis, autophagy and pyroptosis: role in obesity-associated NAFLD
Silvia Ezquerro, Fátima Mocha, Gema Frühbeck, et al.
The Journal of Clinical Endocrinology & Metabolism (2018)
Open Access | Times Cited: 93

The metabolic basis of nonalcoholic steatohepatitis
Manu V. Chakravarthy, Brent A. Neuschwander‐Tetri
Endocrinology Diabetes & Metabolism (2020) Vol. 3, Iss. 4
Open Access | Times Cited: 79

Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, et al.
Processes (2021) Vol. 9, Iss. 1, pp. 135-135
Open Access | Times Cited: 79

Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota
Priyankar Dey, Bryan D. Olmstead, Geoffrey Y. Sasaki, et al.
The Journal of Nutritional Biochemistry (2020) Vol. 84, pp. 108455-108455
Open Access | Times Cited: 71

Lean NAFLD: an underrecognized and challenging disorder in medicine
Sheila Maier, Amanda Wieland, Melanie Cree‐Green, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 351-366
Open Access | Times Cited: 58

Gender Differences in Nonalcoholic Fatty Liver Disease
Aabha Nagral, Manisha Bangar, Sherna Menezes, et al.
Euroasian Journal of Hepato-Gastroenterology (2022) Vol. 12, Iss. S1, pp. S19-S25
Open Access | Times Cited: 47

The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach
Milena Vesković, Nikola Šutulović, Dragan Hrnčić, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9084-9102
Open Access | Times Cited: 27

Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p
Zhibo Zhao, Zhong Li, Peizhi Li, et al.
Experimental Cell Research (2019) Vol. 387, Iss. 1, pp. 111738-111738
Closed Access | Times Cited: 74

Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, et al.
Atherosclerosis (2019) Vol. 284, pp. 66-74
Closed Access | Times Cited: 73

Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway
Qian Chen, Mengyang Liu, Haiyang Yu, et al.
Journal of Natural Medicines (2018) Vol. 72, Iss. 3, pp. 655-666
Closed Access | Times Cited: 71

Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
Monika Augustyn, Iwon Grys, Michał Kukla
Clinical and Experimental Hepatology (2019) Vol. 5, Iss. 1, pp. 1-10
Open Access | Times Cited: 71

Page 1 - Next Page

Scroll to top